More than seven million additional Americans could get coverage for popular drugs such as Zepbound and Wegovy under the ...

Millions of Americans would be eligible to have costly weight-loss drugs like Wegovy or Ozempic covered by Medicare or ...

The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have ...

Joe Biden wants diabetes drugs that aid weight loss and treat obesity, such as Wegovy, to fall under Medicare and Medicaid.

The U.S. pharmaceutical industry is pushing to revamp the new law that allows Medicare to negotiate prices for its costliest ...

Millions more senior citizens and lower-income Americans could obtain coverage for costly anti-obesity drugs under a proposal ...

The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans ...

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.

It's common for Medicare Advantage plans to require prior authorizations for tests or procedures that are out of the ordinary ...

With fewer Part D plans and a $2,000 out-of-pocket cap, beneficiaries must rethink their Medicare drug coverage for 2025.

Several healthcare provider networks in Minnesota are choosing not to accept specific Medicare Advantage plans in 2025 due to ...

According to CMS estimates, passage of the rule would open access to the weight-loss medications to 3.4 million potential new ...